Stocks
Valeant Pharmaceuticals International, Inc.VRX
YHDHealthcarePharmaceuticals
A specialty pharmaceutical company focused on developing, manufacturing, and marketing branded and generic drugs across areas such as dermatology, gastroenterology, and eye health through its Bausch + Lomb division. The business historically relied on acquisitions to expand its portfolio and global ...
Congressional Interest in Valeant Pharmaceuticals International, Inc. (VRX)
4 members of Congress have disclosed 7 trades in Valeant Pharmaceuticals International, Inc. (VRX), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 4 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
7
Unique Politicians
4
Buys
3
Sells
4
Who in Congress Is Trading VRX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-09-27 | JAMES B. RENACCI | buy | $1K – $15K |
| 2016-02-19 | MICHAEL T. MCCAUL | buy | $1K – $15K |